Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Goyang
Clinical trial register · South Korea

Clinical Trials in Goyang, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3365 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:17 UTC
3365
Studies in scope
all four open statuses
1831
Recruiting now
open to new participants
500
Lead sponsors
across recruiting studies
Top sites
Seoul 2821 Daegu 554 Seongnam-si 493 Busan 468 Goyang-si 396
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
National Cancer Center, Korea5 Seoul National University Hospital4 Boehringer Ingelheim4 Samsung Medical Center3 Daiichi Sankyo2
Site location
Seoul2821 Daegu554 Seongnam-si493 Busan468 Goyang-si396
All 252 locations
Target enrolment
to

Trials with a site in Goyang

51 of 3365 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Ulsan, Goyang-si, Namdong-gu, Busan, Seoul, Bucheon-si, Goyang, Iksan
2026-12-16
Not yet open
Edoxaban Versus Apixaban in Cancer-Associated Venous Thromboembolism
NCT07852637Venous Thromboembolism, Active Cancer
DrugsEdoxaban·Apixaban
Samsung Medical Center
Phase 4
2,300
Goyang-si, Busan, Goyang, Gwangmyeong, Hwasun, Jeonju, Seoul
2026-11-01
Recruiting
Sanofi
Observational
706
Busan, Daegu, Goyang, Gwangju, Hanam, Iksan, Seongnam, Seoul
2026-07-01
Recruiting
Boehringer Ingelheim
Phase 3
286
Busan, Gangnam-gu, Goyang, Seoul, Suwon
2026-02-16
Not yet open
Effect of Exercise on Chemotherapy-Induced Peripheral Neuropathy
NCT07399561Peripheral Neuropathy, Secondary to Drugs or Chemicals, Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients, Paclitaxel Induced Neuropathy
National Cancer Center, Korea
Not applicable
140
Goyang
2026-02-03
Recruiting
Boehringer Ingelheim
Phase 3
400
Goyang, Seongnam, Seoul, Suwon
2026-01-16
Not yet open
Inha University Hospital
Phase 4
1,898
Incheon, Ansan, Bucheon-si, Busan, Cheonan, Goyang, Goyang-si, Guri-si
2026-01-01
Recruiting
ROKIT Healthcare
Phase 4
104
Daegu, Bucheon-si, Guri-si, Gwangmyeong, Seongnam-si, Goyang, Incheon, Jeonju
2025-12-29
Recruiting
Boehringer Ingelheim
Phase 3
670
Busan, Daejoen, Goyang, Hwasun, Seongnam, Seoul
2025-11-07
Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
NCT07011719Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma
DrugsCasdatifan·Cabozantinib
Arcus Biosciences, Inc.
Phase 3
720
Busan, Daejeon, Goyang, Seongnam, Seoul, Suwon
2025-09-08
Recruiting
Celcuity Inc
Phase 3
1,180
Goyang, Incheon, Seongnam-si, Seoul, Suwon, Ulsan
2025-07-24
Recruiting
Pusan National University Yangsan Hospital
Phase 2
186
Daegu, Daejeon, Goyang, Hwasun, Incheon, Jeonju, Seongnam, Seoul
2025-07-23
Recruiting
Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients
NCT07405931Early Gastric Cancer, Advanced Gastric Cancer, Early Lung Cancer, Advanced Lung Cancer
Ulsan University Hospital
Not applicable
414
Busan, Goyang, Incheon, Jinju, Ulsan
2025-07-09
Recruiting
NGM Biopharmaceuticals, Inc
Phase 2
136
Goyang, Incheon, Seoul, Suwon
2025-06-25
Recruiting
Immunovant Sciences GmbH
Phase 2
210
Daegu, Goyang, Guri-si, Seoul
2025-06-19
Recruiting
Effectiveness of ERAS on Postoperative Recovery After Minimally Invasive Gastrectomy
NCT06984952Enhanced Recovery After Surgery, Gastrectomy for Gastric Cancer
Seoul National University Hospital
Not applicable
308
Busan, Daegu, Daejeon, Goyang, Seongnam, Seoul, Suwon
2025-06-13
Recruiting
BioNTech SE
Phase 3
480
Changwon, Daegu, Goyang, Seongnam, Seongnam-si, Seoul
2025-06-10
Recruiting
Streamlining Radioembolization for Small HCC
NCT06979219Hepatocellular Carcinoma (HCC)
Seoul National University Hospital
Observational
146
Goyang, Seongnam-si, Seoul
2025-06-10
Active, closed
Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization
NCT06767345Coronary Artery Disease, Atherosclerosis of Coronary Artery, Plaque, Atherosclerotic
Korea University Anam Hospital
Phase 4
408
Seoul, Goyang, Suwon
2025-05-12
Recruiting
Same-day Radioembolization for Large HCC
NCT06944483Hepatocellular Carcinoma (HCC)
Seoul National University Hospital
Observational
138
Goyang, Seoul
2025-04-25
Recruiting
National Cancer Center, Korea
Phase 2
128
Goyang, Seoul
2025-04-15
Recruiting
Imjudo & Imfinzi PMS
NCT06544629Hepatocellular Carcinoma
AstraZeneca
Observational
246
Busan, Goyang, Seongnam, Seoul, Suwon
2025-04-14
Recruiting
Samsung Medical Center
Not applicable
1,200
Ansan, Daegu, Gangneung, Goyang, Gwangju, Gwangmyeong, Incheon, Jeonju
2025-04-07
Recruiting
SB17170 Phase 2 Trial in IPF Patients
NCT06747923IPF, Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF)
DrugSB17170
SPARK Biopharma
Phase 2
30
Goyang, Gwangmyeong, Seoul, Suwon
2025-01-27
Recruiting
A Study of IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor
NCT06365840TMB-H, Histologically or Cytologically Proven Metastatic or Locally Advanced Solid Tumors
DrugDanburstotug
ImmuneOncia Therapeutics Inc.
Phase 2
30
Goyang, Seongnam, Seoul
2025-01-13
Recruiting
AbbVie
Observational
3,000
Busan, Daejeon, Gangwon-do, Gwangju, Ansan-si, Goyang, Goyang-si, Hwaseong
2024-09-24
Active, closed
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
1,942
Busan, Daegu, Donggu, Goyang, Seoul, Uijeongbu-si, Ulsan
2024-03-13
Active, closed
Boehringer Ingelheim
Phase 3
428
Cheongiu, Goyang, Incheon, Seoul, Suwon
2024-02-09
Active, closed
BicycleTx Limited
Phase 2
375
Daejeon, Goyang, Seoul
2024-01-24
Recruiting
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
NCT05875168Advanced Solid Tumor, Metastatic Solid Tumor
Daiichi Sankyo
Phase 1/2
590
Goyang, Seongnam-si, Seoul
2023-08-18
Recruiting
Vividion Therapeutics, Inc.
Phase 1
290
Goyang, Incheon, Seongnam, Seoul, Suwon
2023-07-28
Active, closed
Regeneron Pharmaceuticals
Phase 2
51
Seoul, Hwasun, Goyang
2023-04-21
Active, closed
Study of Novel Treatment Combinations in Patients With Lung Cancer
NCT05633667Lung Cancer, Advanced or Metastatic Non-Small-Cell Lung Cancer, Resectable Non-Small-Cell Lung Cancer
DrugsDomvanalimab·Zimberelimab·Sacituzumab Govitecan·Nab-paclitaxel
Gilead Sciences
Phase 2
192
Cheongju-si, Goyang, Gwangju, Gyeonggi-do, Seogu, Seoul
2023-03-16
By invitation
National Cancer Center, Korea
Observational
6,923
Goyang
2023-01-02
Recruiting
Seoul National University Hospital
Phase 3
236
Busan, Daegu, Goyang, Hwasun, Seongnam, Seoul, Suwon
2022-12-15
Active, closed
Gilead Sciences
Phase 3
1,021
Gangnam-Gu, Goyang, Heungdeok-Gu, Inchon, Seoul, Suwon
2022-10-12
Active, closed
Seoul National University Bundang Hospital
Observational
1,000
Bucheon-si, Chungju, Daegu, Daejeon, Goyang, Hwasun, Incheon, Jeonju
2022-09-28
Active, closed
AstraZeneca
Phase 2
194
Goyang, Seoul
2022-08-11
Active, closed
Daiichi Sankyo
Phase 3
586
Cheongju-si, Goyang, Seongnam, Seoul
2022-07-08
Active, closed
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
496
Goyang, Seongnam, Seoul, Yangsan
2021-03-18
Recruiting
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
NCT04502394Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma
DrugsNavtemadlin·Acalabrutinib
Kartos Therapeutics, Inc.
Phase 1/2
84
Goyang, Incheon, Seoul
2021-02-23
Recruiting
BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
NCT04421820Colorectal Cancer, Pancreatic Cancer, Gastric Cancers, Cholangiocarcinoma
DrugsFolfox·Oxaliplatin
Bold Therapeutics, Inc.
Phase 1/2
220
Goyang, Seoul
2020-08-28
Active, closed
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
NCT04498117Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer, Ovarian Serous Adenocarcinoma
DrugsOregovomab·Paraplatin·Taxol·Paclitaxel
CanariaBio Inc.
Phase 3
615
Goyang, Seongnam, Seoul, Soeul
2020-08-25
Recruiting
National Cancer Center, Korea
Phase 3
1,700
Busan, Chuncheon, Daegu, Goyang, Gwangju, Incheon, Seoul
2020-02-15
Active, closed
Takeda
Phase 3
354
Cheongju-si, Busan, Goyang, Jeongnam, Seoul
2020-01-10
Active, closed
Dizal Pharmaceuticals
Phase 1/2
315
Cheonju, Goyang, Seongnam, Seoul, Suwon
2019-07-09
Active, closed
Avelumab Program Rollover Study
NCT03815643Solid Tumors
DrugAvelumab
EMD Serono Research & Development Institute, Inc.
Phase 3
205
Cheongju-si, Daejeon, Goyang, Incheon, Seoul
2019-03-22
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
387
Goyang, Seoul
2019-01-23
Active, closed
INsTantenous wavE-Free Ratio-guided PCI Versus Fractional Flow REserve-Guided PCI in rouTine Clinical Practice, Prospective, Multicenter Registry
NCT03338309Stable Angina, Non ST Segment Elevation Myocardial Infarction, ST-segment Elevation Myocardial Infarction, Silent Myocardial Ischemia
Samsung Medical Center
Observational
1,200
Daegu, Goyang, Seoul
2017-11-01
Active, closed
Exelixis
Phase 4
247
Goyang, Seoul
2015-02-25
Active, closed
Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population
NCT02112214Gastric Cancer, Helicobacter Pylori Infection
National Cancer Center, Korea
Phase 3
5,224
Busan, Chuncheon, Daegu, Goyang, Gwangju, Incheon, Seoul, Uijeongbu-si
2014-06
Rows per page Showing 1–51 of 51
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 October 2026. https://priyalifescience.com/clinical-trials-south-korea/city/goyang

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,365 studies in total at the last sync on 11 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 51 of those studies with a site in Goyang.

How many clinical trials are recruiting in Goyang?

28 of the 51 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:17 UTC sync. A further 4 have not yet opened recruitment, 18 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Goyang), 51 studies
PhaseStudiesRecruitingShare
Phase 317833.3%
Phase 210619.6%
Observational8515.7%
Not applicable539.8%
Phase 1/2549.8%
Phase 4519.8%
Phase 1112%

Most active sponsors

Lead sponsors with the most studies (Goyang)
Lead sponsorStudiesRecruiting
National Cancer Center, Korea52
Boehringer Ingelheim43
Seoul National University Hospital44
Samsung Medical Center31
AstraZeneca21
Daiichi Sankyo21
Gilead Sciences20
Regeneron Pharmaceuticals21
AbbVie11
Arcus Biosciences, Inc.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.